Standard Protocol Items for Clinical Trials with Traditional Chinese Medicine 2018: Recommendations, Explanation and Elaboration (SPIRIT-TCM Extension 2018)
Traditional Chinese Medicine (TCM) is one of the oldest systems of medicine. More and more attention has been paid to TCM application, but the variable quality of clinical trials with TCM impedes its widespread acceptance. The Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2013 Statement has established guidelines for designing clinical trials to ensure that the trial results are accurate and reliable. However, there are difficulties when applying SPIRIT 2013 Statement to trials with TCM, due to the unique theory and the characteristic of TCM intervention. An Extension to the original SPIRIT was developed to ensure the quality of trial design with TCM. As Chinese herbal formulae, acupuncture and moxibustion are common and representative interventions in TCM practice, the executive working group determined that the SPIRIT-TCM Extension focus on these three interventions. Extension was developed through initiation, 3 rounds of Delphi consensus survey, and finalizing expert meeting. Seven items from the SPIRIT 2013 Statement were modified, namely, "title", "background and rationale", "objectives", "eligibility criteria", "interventions", "outcomes", and "data collection methods". The Extension includes the introduction of the concept of TCM pattern and 3 major TCM interventions, with examples and explanations. The SPIRIT-TCM Extension 2018 provides suggestion for investigators in designing high quality TCM clinical trials. It is expected that wide dissemination and application of this extension ensure continuous improvement of TCM trial quality throughout the world.
KeywordsSPIRIT traditional Chinese medicine clinical trial extension recommendation
Unable to display preview. Download preview PDF.
We thanks David Moher for his critical comments about this project. Special thanks for Dr. Martha Dahlen for her help in polishing this manuscript.
- 1.World Health Organization. WHO traditional medicine strategy 2014–2023. Accessed Dec 2013. Cited 20 Dec 2017. Available from: https://doi.org/apps.who.int/iris/bitstream/10665/92455/1/9789241506090_eng.pdf?ua=1.
- 2.Chen KJ, Qian ZH, Zhang WQ, Guan WR, Wu XG, Chen XJ, et al. Effectiveness analysis for double blinded treatment with refined coronary tablets on angina pectoris leaded by coronary heart disease in 112 cases. J Med Res (Chin) 1982;11:24–25.Google Scholar
- 7.Cheng CW, Wu TX, Shang HC, Li YP, Altman DG, Moher D, et al. CONSORT extension for Chinese herbal medicine formulae 2017: recommendations, explanation and elaboration. Ann Intern Med 2017 Jun 27. doi: 10.7326/M16-2977.Google Scholar
- 9.The SPIRIT Statement. Endorsement. Accessed 20 Dec 2017. Available at: https://doi.org/www.spirit-statement.org/aboutspirit/spirit-endorsement.
- 10.Zhong LD, Cheng CW, Wu TX, Li YP, Shang HC, Zhang BL, et al. SPIRIT 2013 statement: define standard protocol items for clinical trials. Chin J Integr Tradit West Med (Chin) 2014;34:115–122.Google Scholar
- 11.Han M, Yang GY, Wang YY, Liu JP. Chinese medicine clinical trial protocol design and report specifications. Chin J Integr Tradit West Med (Chin) 2014;34:907–910.Google Scholar
- 12.Shen WJ, Wu XK, Wang GY, Liu JP. Common problems and solving strategy of clinical trial protocols of traditional Chinese medicine. Acta Chin Med Pharmacol (Chin) 2015;43:1–4.Google Scholar
- 13.Integrative Traditional and Western Medicine Branch of Chinese Medical Doctor Association, Evidence-based Medicine Professional Committee of Chinese Integrative Medicine Association. Methodology guideline for clinical studies investigating traditional Chinese medicine and integrative medicine}. Chin J Integr Tradit West Med (Chin)} 2015};35}:901–Google Scholar
- 14.Liu YX. Randomization of clinical trials. J Med Postgrad (Chin) 2015;28:113–117.Google Scholar
- 19.World Health Organization. WHO international standard terminologies on traditional medicine in the western pacific region. 2007. Accessed 20 Dec 2017. Available at: https://doi.org/www.wpro.who.int/publications/who_istrm_file.pdf.
- 21.Tang Q. Syndrome diagnosis criteria and therapeutic schedule for depression. J Beijing Univ Tradit Chin Med (Chin) 2011;34:810–811.Google Scholar
- 22.Li J, Wang Z, Li S, Li Y, Zhang HC, Chao E, et al. Syndrome diagnosis criteria for common cold (2013 version). J Tradit Chin Med (Chin) 2014;55:350–351.Google Scholar
- 27.Zhang ZZ, Tian D, Xing J, Li ZY, Qin XM. Quality comparison on Farfarae Flos from various origins by UPLC based on multi-components content determination method. Chin Tradit Herb Drugs (Chin) 2015;46:2296–2302.Google Scholar
- 28.Zhang S, Mu W, Xiao L, Zheng WK, Liu CX, Zhang L, et al. Is deqi an indicator of clinical efficacy of acupuncture? A systematic review. Evid Based Complement Alternat Med 2013;2013:750140.Google Scholar
- 34.Zhang L, Zhang J, Chen J, Xing D, Mu W, Wang J, et al. Clinical research of traditional Chinese medicine needs to develop its own system of core outcome sets. Evid Based Complement Alternat Med 2013;2013:202703.Google Scholar
- 35.Administration CFDA. Announcement of self-examination and inspection of drug clinical trial data. 2015. Accessed 20 Dec 2017. Available at: https://doi.org/www.sda.gov.cn/WS01/CL0087/124800.html.